The University of Ottawa Heart Institute is proud to announce that renowned cardiologist and clinician-scientist, Dr. Rob Beanlands, has been appointed as its next president and chief executive officer. Congratulations, @BeanlandsRob! Read more: ow.ly/zsNS50Qs6aa#ottnews
Fragmented data systems can slow health research in Canada. ARCHIMEDES, a new national platform launched by the @HeartInstitute with @mcgillu and @uOttawa, enables secure data sharing and advanced analytics to accelerate discovery and innovation.
đź”—ow.ly/oSTw50YpJQi
Dr. Hassan Mir is chair of the Ottawa Model for Smoking Cessation. His session introduces two complementary sets of guidelines and asks: what works best and how do we operationalize them in smoking cessation care? 🤔
That’s a wrap on the first day of the 18th Annual Ottawa Conference. A lot has changed over the years, but our dedication to smoking cessation remains strong.
At the Ottawa Conference, Ashley and Brianna—clinical research coordinators at the Ottawa Heart Institute—spotlight the critical role of research in smoking cessation.
Dr. Andrew Pipe and Dr. Hassan Mir—two of Canada’s foremost leaders in clinical smoking cessation—kicked off the Ottawa Conference with an engaging opening on contemporary issues and real-world practice in smoking cessation.
Dr. Rob Beanlands, president & CEO of the Ottawa Heart Institute, warmly welcomes delegates to the 18th Annual Ottawa Conference! Stay tuned for a day focused on state-of-the-art clinical approaches to smoking cessation. 👏
We’re live and underway at the 18th Annual Ottawa Conference: State-of-the-Art Clinical Approaches to Smoking Cessation! 🎉 Looking forward to a great day of evidence, innovation and practical insights.
SAVE THE DATE! đź“…
Join us for the 4th Annual Rare Cardiac Conditions Conference. This one-day virtual event brings together multidisciplinary speakers to explore the challenges and opportunities in understanding and treating rare cardiac conditions.
🔗ottawaheart.ca/researchers/c…
What a pleasure to kick off our first research conference of 2026, our 50th anniversary year, with our very own George Wells, PhD, Director and Principal Investigator of the Cardiovascular Research Methods Centre.💡🫀